Maciten Tablet

Maciten Tablet
Product Description

1. Active Ingredient & Strength : Micronized Macitentan 10 mg 2. Indication : Pulmonary arterial hypertension (PAH) 3. Characteristics : - Dual ERA (bosentan + ambrisentan) - Long-term treatment of adult patients with PAH (WHO Group I) corresponding to WHO functional classifications II to III 4. Development Status : BE test completed 5. Dossier : CTD available

Read more Show less

Samjin Pharmaceutical Co., Ltd.

  • Country/Region:
    Korea, Republic Of
  • On CPHI since:
    2022
  • Certificates:
    2
  • Employees:
    500 - 999
Company types
CMO/CDMO
Generics/Biosimilars Manufacturer
OTC
Pharmaceutical company
Primary activities
API Producer
Pharmaceutical Company (generic finished products)
View company profile
Categories
more categories Show less
Specifications
  • Supplied from
    Korea, Republic Of
More specifications Fewer specifications
Sales Markets
Show more Show less

Samjin Pharmaceutical Co., Ltd.

  • Country/Region:
    Korea, Republic Of
  • On CPHI since:
    2022
  • Certificates:
    2
  • Employees:
    500 - 999
Company types
CMO/CDMO
Generics/Biosimilars Manufacturer
OTC
Pharmaceutical company
Primary activities
API Producer
Pharmaceutical Company (generic finished products)
View company profile

More Products from Samjin Pharmaceutical Co., Ltd. (2)

  • Clopidogrel Tablet

    Product Clopidogrel Tablet

    Indication: Antiplatelet API: Clopidogrel Bisulfate 75mg BE data: Available CTD: Available Export: Philippines, Singapore.
  • Letrozole Tablet

    Product Letrozole Tablet

    Oncology Indication: Postmenopausal hormone receptor-positive breast cancer API: Letrozole 2.5mg BE data: Available CTD: Available

Samjin Pharmaceutical Co., Ltd. resources (1)